Ogilvy Group has adopted a “poison pill”...
Ogilvy Group has adopted a “poison pill” anti-takeover plan, which would make a takeover prohibitively expensive. The move caused shares of Ogilvy, the sixth-largest U.S. advertising agency, to drop $1.25 to $31.25 on the NASDAQ market after it announced that its board passed the plan at a special meeting. Ogilvy stock had risen sharply in recent days on takeover talk. But the New York company, whose main subsidiary is Ogilvy & Mather Worldwide, said it knew of no suitors.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.